Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Topics Sessions Videos Previous meetings

Posters by Session

Select Session

Thumbnail for Uncovering Germline Leukemia Predisposition Through Integrated Clinical and Somatic Genomic Analysis

ALL - 1245

Uncovering Germline Leukemia Predisposition Through Integrated Clinical and Somatic Genomic Analysis

Kamila Wypyszczak

Poster Presenter: Kamila Wypyszczak

Thumbnail for Real-World Incidence and Management of CRS and ICANS in Adults With Newly Diagnosed Philadelphia Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia Treated With Frontline TKI Plus Blinatumomab

ALL - 1307

Real-World Incidence and Management of CRS and ICANS in Adults With Newly Diagnosed Philadelphia Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia Treated With Frontline TKI Plus Blinatumomab

Rosa Ancaya

Poster Presenter: Rosa Ancaya

Previous 1...12 13 14 15 16 17 18...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Outcomes After TKI Discontinuation in Patients with Ph+ ALL Treated With Blinatumomab and Ponatinib

ALL - 1317

Outcomes After TKI Discontinuation in Patients with Ph+ ALL Treated With Blinatumomab and Ponatinib

Abigail Huetteman

Poster Presenter: Abigail Huetteman

Thumbnail for Comparative Performance of Multimodal Large Language Models in Acute Leukemia Morphology

ALL - 1320

Comparative Performance of Multimodal Large Language Models in Acute Leukemia Morphology

Miranda Lin

Poster Presenter: Miranda Lin

Thumbnail for Myeloablative vs Reduced-Intensity Conditioning With Post-Transplant Cyclophosphamide in Matched Unrelated Donor Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia: A CIBMTR Registry Analysis

ALL - 1355

Myeloablative vs Reduced-Intensity Conditioning With Post-Transplant Cyclophosphamide in Matched Unrelated Donor Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia: A CIBMTR Registry Analysis

Muhammad Salman Faisal

Poster Presenter: Muhammad Salman Faisal

Thumbnail for Changes in Thoracic Body Composition After Induction Chemotherapy and Outcomes in Patients With Acute Lymphoblastic Leukemia

ALL - 1372

Changes in Thoracic Body Composition After Induction Chemotherapy and Outcomes in Patients With Acute Lymphoblastic Leukemia

Frida Rodriguez-Contreras

Poster Presenter: Frida Rodriguez-Contreras

Thumbnail for Optimizing Donor Age for Allogeneic Transplant in Acute Lymphoblastic Leukemia in the Era of Posttransplant Cyclophosphamide-Based Graft-Versus-Host Prophylaxis

ALL - 1394

Optimizing Donor Age for Allogeneic Transplant in Acute Lymphoblastic Leukemia in the Era of Posttransplant Cyclophosphamide-Based Graft-Versus-Host Prophylaxis

John Behman

Poster Presenter: John Behman

$Thumbnail for Safety and Early Clinical Outcomes of Dual-Target CD19/CD22 CAR-T Strategies in Relapsed/Refractory B-ALL: A Systematic Review and Meta-Analysis$

ALL - 1407

Safety and Early Clinical Outcomes of Dual-Target CD19/CD22 CAR-T Strategies in Relapsed/Refractory B-ALL: A Systematic Review and Meta-Analysis

Mohamed Mostafa Ibrahim

Poster Presenter: Mohamed Mostafa Ibrahim

Thumbnail for Allogeneic Hematopoietic Cell Transplantation After CAR-T Therapy in B-Cell Acute Lymphoblastic Leukemia: A Meta-Analysis of Survival and Relapse Outcomes

ALL - 1457

Allogeneic Hematopoietic Cell Transplantation After CAR-T Therapy in B-Cell Acute Lymphoblastic Leukemia: A Meta-Analysis of Survival and Relapse Outcomes

Yumna Khalid

Poster Presenter: Yumna Khalid

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors